Promega - celltox green express cytotoxicity assay for menghang XIA
Ended Awarded
- Contract number
- HHSN31900003
- Awardee
-
Promega Corporation UEI MWM4N9L4S5X4
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,226
Award facts
- Contract value 100% obligated
- $14,225.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53711, USA
Award details come from SAM.gov/FPDS.
About this award
Promega Corporation, a Madison, Wisconsin-based life sciences manufacturer, was awarded a $14,225.70 firm fixed price contract on September 25, 2014, for the CellTox Green Express Cytotoxicity Assay, with completion targeted for February 28, 2015. This award was issued as a call under Promega's existing $10 million Blanket Purchase Agreement with the National Institutes of Health's Office of Logistics and Acquisition Operations and was funded by the National Center for Advancing Translational Sciences, a civilian NIH component focused on translational research and biomedical innovation. No small business set-aside designation was utilized for this contract.
The CellTox Green Express Cytotoxicity Assay represents a specialized research reagent supporting cell-based research activities at the federal level. This purchase was executed through Promega's established BPA vehicle, which enables efficient procurement of biological materials, chemicals, medical and scientific equipment, and associated maintenance services across multiple NIH centers and institutes. The award reflects continued reliance on Promega's established capabilities as a large business provider of advanced scientific consumables and diagnostic assays to federal agencies engaged in translational science and research missions.
Quick answers
Who was awarded contract HHSN31900003?
HHSN31900003 was awarded to Promega Corporation by National Center for Advancing Translational Sciences (National Institutes of Health) on September 25, 2014.
How much is contract HHSN31900003 worth?
The government has obligated $14,226 on HHSN31900003.
Is contract HHSN31900003 an order under another contract?
Yes. HHSN31900003 is a BPA call under HHSN263199900051808B, a blanket purchase agreement.
Was contract HHSN31900003 competed?
The extent of competition for HHSN31900003 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award